Public Disclosure of Agreement. The Lender and the Contractor agree that the Province will be at liberty to make public disclosure of this Agreement, excepting only any portions thereof that the Lender or the Contractor has, prior to signing of this Agreement, established to the satisfaction of the Province, acting reasonably, would be exempted from disclosure under Part 1 of FOIP by the provisions of FOIP governing third party confidential information.
Public Disclosure of Agreement. Notwithstanding the above Sections 19.4 and 19.5, the Contractor agrees that the Province will be at liberty to disclose all information contained in this Agreement, excepting only any Schedules or portions thereof that the Contractor has, prior to signing of this Agreement, established to the satisfaction of the Province, acting reasonably, contain information that:
(a) would reveal trade secrets, or commercial, financial, labour relations, scientific or technical information of the Contractor;
(b) is being supplied in confidence to the Province; and
(c) if disclosed, could reasonably be expected to harm significantly the competitive position or interfere significantly with the negotiating position of the Contractor, (the “Sensitive Information”). In the event of a request under FOIP for access to any of the Sensitive Information, the Contractor will be given notice of the request pursuant to FOIP and will be given an opportunity to make representations as to why the information should not be disclosed. The Province acknowledges that the financial, commercial and technical information contained in the Contractor’s Proposal (including but not limited to the financial model contained therein) has been submitted to the Province in confidence.
Public Disclosure of Agreement. The Parties agree that this Agreement will be publicly disclosed by Institution in the contract register pursuant to the Act no. 340/2015 Coll. (the “Act”) within thirty (30) days of its execution. The Parties acknowledge that the Budget and Payment Schedule in Exhibit A and any other exhibits and attachments to this Agreement are deemed business secret of Gilead in accordance with the Act and Institution and Investigator shall ensure that such information will not be published in the contract register. CRO or Gilead will provide Institution with version of Agreement that will be published to ensure that business secret of Gilead are not published. Institution shall provide Gilead with written email confirmation of such registration to: ▒▒▒▒▒▒▒▒▒ within 24 hours after registration occurs. The Parties agree that no activities under this Agreement will be conducted until Gilead has received such confirmation. Institution assumes all liability for failure to so publish. Soudní zákaz. Zdravotnické zařízení bere na vědomí, že jakékoli skutečné nebo hrozící porušení Článku 4 způsobí společnosti Gilead nevyhnutelné a nenapravitelné škody, které nelze adekvátně uhradit finančně, a proto Zdravotnické zařízení souhlasí s tím, že společnost Gilead nebude muset prokázat nenapravitelnou škodu ve snaze uplatnit nebo získat soudní zákaz ve spojení se skutečným nebo hrozícím porušením Článku 4. Kromě jakéhokoli soudního příkazu může společnost Gilead usilovat o jakákoli jiná zákonná nebo opodstatněná nápravná opatření.
Public Disclosure of Agreement. The Parties agree that, if required by applicable laws, this Agreement will be publicly disclosed by Institution in the contract register pursuant to the Act no. 340/2015 Coll. (the “Act”) within thirty (30) days of its execution. The Parties acknowledge that the Budget and Payment Schedule in Exhibit A and any other exhibits and attachments to this Agreement are deemed business secret of Gilead in accordance with the Act and Institution and Investigator shall ensure that such information will not be published in the contract register. Institution assumes all liability for failure to so publish. 5. PUBLICATION 5.1 Institution and Investigator may publish or present the results of the Trial generated by Institution and Investigator (the “Trial Results”) either: (i) with the advance written consent of Gilead; or (ii) 2 years after the completion of the Trial at all participating institutions (each, a “Publication”). Investigator informace a (y) okamžitě xx xxx xxxxx společnosti Gilead, nebo, budou-li o to společností Gilead požádáni, zničí veškeré Důvěrné informace, včetně jakýchkoli kopií, výňatků, souhrnů nebo z nich odvozených děl, a písemně potvrdí společnosti Gilead, že takové informace odevzdali a/nebo zničili; nicméně za předpokladu, že si Instituce a Zkoušející mohou ponechat jednu (1) kopii Důvěrných informací ve svých právních archivech výhradně pro účely monitorování svých přetrvávajících závazků vyplývajících z této Smlouvy. 4.5 O patření ochranného charakteru. Instituce a Zkoušející berou na vědomí, že jakékoli skutečné nebo hrozící porušení Článku 4 způsobí společnosti Gilead nevyhnutelné a nenapravitelné škody, které nelze adekvátně uhradit finančně, a proto Instituce a Zkoušející souhlasí s xxx, že společnost Gilead nebude muset prokázat nenapravitelnou škodu ve snaze uplatnit opatření ochranného charakteru ve spojení se skutečným nebo xxxxxxxx xxxxxxxxx Xxxxxx 0. Xxxxx jakéhokoli opatření ochranného charakteru může společnost Gilead usilovat o jakákoli xxxx nápravná opatření podle zákona nebo práva ekvity.
Public Disclosure of Agreement. The Recipients agree that the Province shall be at liberty to make public disclosure of this Agreement, excepting only any portion of Schedules “A”, “B”, “C”, “F” and “G” that: (i) the Recipients have, prior to the signing of this Agreement, established to the satisfaction of the Province, acting reasonably, that such portion would be exempted from disclosure under Part 1, Division 2 of the FOIP Act by the provisions thereof governing third party confidential information, or (ii) may otherwise be excluded from such public disclosure as determined by mutual agreement, subject always to the access to information provisions (and exceptions thereto) of the FOIP Act. The Province acknowledges that the financial, commercial and technical information contained in the Recipients’ proposal submitted in response to the FPP Information Package was provided to the Province in confidence, subject to the FOIP Act. Until such time as the Province has made public disclosure of this Agreement in accordance with the foregoing, the Recipients shall maintain in confidence and not disclose: (i) this Agreement (and the contents thereof including without limitation all schedules to this Agreement), and (ii) the letter of intent between the Parties dated September 23, 2009 (and the contents thereof) unless such documents or any part thereof:
(a) are compelled by law to be disclosed;
(b) have been or are subsequently received from another person absent an obligation of confidentiality; or
(c) are or become part of the public domain other than in breach of the foregoing obligations; provided, however, that the Recipients shall be entitled to disclose such documents to its legal, accounting and financial advisors, and to its Affiliates, lenders, investors and consultants, on a need-to-know basis subject to such persons being bound by written confidentiality obligations which are consistent with the foregoing, or in the alternative, professional duties that impose a duty of confidentiality upon such persons with respect to such documents (and the Recipients shall not waive any such duties), and further provided that any disclosure by such persons in breach of their confidentiality obligations owing to the Recipients shall be deemed to be a breach by the Recipients of their foregoing confidentiality obligations owing to the Province.
Public Disclosure of Agreement. The Parties agree that this Agreement will be publicly disclosed by Institution in the contract register pursuant to Act no. 40/1964 Coll. Civil Code (the “Act”) within the statutory time limit provided under the Act. The Parties acknowledge that the Budget and Payment Schedule in Exhibit A and any other exhibits and attachments to this Agreement are deemed business secret of Gilead in accordance with the Act and Institution and
Public Disclosure of Agreement. Owner acknowledges that Beacon Properties Corporation, the general partner of Operating Partnership, is a publicly owned corporation subject to regulation by the Securities and Exchange Commission ("SEC"), and that the regulations of the SEC may require that Operating Partnership disclose the existence of this Agreement and the contents of some or all of the Documents delivered by Owner. Accordingly, Owner expressly consents to the disclosure of the terms and conditions of this transaction, this Agreement itself, and terms of any Document which Operating Partnership in good faith believes should be disclosed in connection with fulfillment of its disclosure requirements under SEC regulations. In addition, Operating Partnership and Owner shall have the right to issue press releases announcing this transaction at any time after the date hereof. Each shall be entitled to a prior review of the other's press release.
Public Disclosure of Agreement. The Parties agree that this Agreement will be
Public Disclosure of Agreement. 15.01 No public disclosure of this Agreement shall be made by either party without prior review and consent of the other party, which consent shall not be unreasonably withheld. Notwithstanding the foregoing:
(a) Either party may disclose the existence and nature of this Agreement to its shareholders, but only to the extent necessary to comply with applicable securities laws:
(b) BSI may disclose any or all of the following information, but not in greater detail than that which follows: Minneapolis, Minnesota - October 17, 1990 - Bio-Metric Systems, Inc. (BSI) announced it has entered into an agreement with Xxxxxx Laboratories, Xxxxxx Park, Illinois, relating to diagnostic products developed by BSI. Bio-Metric Systems, Inc. of Minneapolis, Minnesota is a privately-held company, developing advanced biological coatings and diagnostic formats. Xxxxxx Laboratories is a world leader in diagnostics and offers a broad and diversified line of human health care products and services.
15.02 Neither party shall use the name of the other party in connection with any commercial activity, advertising or sales promotion without the prior written consent of the other party.
Public Disclosure of Agreement. Seller acknowledges that Beacon Properties Corporation, the general partner of Buyer, is a publicly owned corporation subject to regulation by the Securities and Exchange Commission ("SEC"), and that the regulations of the SEC may require that Buyer disclose the existence of this Agreement and the contents of some or all of the Documents delivered by Seller. Accordingly, Seller expressly consents to the disclosure of the terms and conditions of this transaction, this Agreement itself, and terms of any document which Buyer in good faith believes should be disclosed in connection with fulfillment of its disclosure requirements under SEC regulations. In addition, Buyer shall have the right to issue press releases announcing this transaction at any time after the expiration of the Due Diligence Period. Seller shall be entitled to a prior review and approval (not to be unreasonably withheld) of the press release. If for any reason this Contract terminates and the Closing does not occur, Buyer, upon written request of Seller shall return all Due Diligence Items to Seller and shall not retain any copies thereof, and shall keep (and shall use reasonable efforts to cause its agents and representatives to keep) confidential all non-public information concerning the Leases and the tenants under the leases, except as may be required to be disclosed pursuant to judicial order or applicable law.
